Investors long trusted UnitedHealth to deliver earnings beats, despite limited transparency. Now they want answers.

This model aims to provide a more transparent and predictable drug pricing structure, addressing the complexities and ambiguities. Get our list of 10 overlooked stocks—including one paying a 9% ...